www.fdanews.com/articles/143144-biogen-ceo-tries-to-refill-early-stage-drug-pipeline-he-decimated
Biogen CEO Tries to Refill Early-Stage Drug Pipeline He Decimated
January 12, 2012
Biogen Idec CEO George Scangos is trying to solve a problem of his own creation: He must replenish an early-stage drug research pipeline that he decimated after taking over the biotechnology company in 2010.
The Wall Street Journal
The Wall Street Journal